z-logo
open-access-imgOpen Access
Systemic Inflammation Response Index (SIRI) Independently Predicts Survival in Advanced Lung Adenocarcinoma Patients Treated with First-Generation EGFR-TKIs
Author(s) -
Shengli Jiang,
Sisi Wang,
Qianqian Wang,
Chao Deng,
Yuhua Feng,
Fengwang Ma,
JinAn Ma,
Xianling Liu,
Chunhong Hu,
Tao Hou
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s287897
Subject(s) - medicine , erlotinib , adenocarcinoma , oncology , lung cancer , gefitinib , proportional hazards model , exact test , multivariate analysis , survival analysis , biomarker , progression free survival , gastroenterology , cancer , overall survival , epidermal growth factor receptor , biochemistry , chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here